PEDIATRICS Vol. 62 No. 5 November 1978, pp. 842-844
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steigman, A. J.
Right arrow Articles by Hanna, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steigman, A. J.
Right arrow Articles by Hanna, B. A.

Intramuscular Penicillin Administration at Birth: Prevention of Early-Onset Group B Streptococcal Disease

Alex J. Steigman M.D., D.Sc.1, Edward J. Bottone Ph.D.1, and Bruce A. Hanna Ph.D.1

1 Departments of Pediatrics and Microbiology, Mount Sinai School of Medicine of The City University of New York, New York

The large number of deaths in newborns resulting from invasive early-onset group B streptococcal (GBS) disease constitutes a grave challenge. The apparent absence of this affliction in our institution appears to be a dividend of the routine use of penicillin for the prophylaxis of ophthalmia neonatorum in all newborns since 1952. Significant confirmation of the efficacy of parenteral penicillin therapy for this purpose derives from a recent report from Halifax in Canada. It is concerned with 983 newborns weighing less than 2,500 gm at birth in whom no deaths occurred during the study period. This contrasted with ten deaths due to GBS disease in 1,208 similar infants in the preceding year when penicillin was not administered.




This article has been cited by other articles:


Home page
 PediatricsHome page
W. E. Benitz, J. B. Gould, and M. L. Druzin
Antimicrobial Prevention of Early-onset Group B Streptococcal Sepsis: Estimates of Risk Reduction Based on a Critical Literature Review
Pediatrics, June 1, 1999; 103(6): 78e - 78.
[Abstract] [Full Text]

Home page
 Clin. Microbiol. Rev.Home page
A. Schuchat
Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms
Clin. Microbiol. Rev., July 1, 1998; 11(3): 497 - 513.
[Abstract] [Full Text] [PDF]